The lancet. Diabetes & endocrinology
-
Lancet Diabetes Endocrinol · Jan 2018
Randomized Controlled Trial Multicenter StudyModerate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial.
Macroalbuminuria predicts renal and cardiovascular events in patients with type 2 diabetes. We aimed to assess the albuminuria-lowering effects of salt restriction, paricalcitol therapy, or both, in this population. ⋯ AbbVie.